A phase III PETHEMA/GEM randomised trial of post-transplant maintenance in multiple myeloma: superiority of bortezomib

被引：0

作者：

Rosinol, L. ^{[1
]}

Cibeira, M. T. ^{[1
]}

Mateos, M. V. ^{[2
]}

Martinez, J. ^{[3
]}

Oriol, A. ^{[4
]}

Teruel, A. I. ^{[5
]}

Hernandez, D. ^{[6
]}

Lopez Jimenez, J. ^{[7
]}

de la Rubia, J. ^{[8
]}

Granell, M. ^{[9
]}

Besalduch, J. ^{[10
]}

Palomera, L. ^{[11
]}

Gonzalez, Y. ^{[12
]}

Etxebeste, M. A. ^{[13
]}

Diaz-Mediavilla, J. ^{[14
]}

Hernandez, M. ^{[15
]}

de Arriba, F. ^{[16
]}

Alegre, A. ^{[17
]}

Lahuerta, J. J. ^{[3
]}

San Miguel, J. ^{[2
]}

Blade, J. ^{[1
]}

机构：

[1] Hosp Clin Barcelona, Barcelona, Spain

[2] Hosp Clin Salamanca, Salamanca, Spain

[3] Hosp 12 Octubre, E-28041 Madrid, Spain

[4] Hosp Badalona Germans Trias & Pujol, Badalona, Spain

[5] Hosp Clin, Valencia, Spain

[6] Hosp La Paz, Madrid, Spain

[7] Hosp Ramon & Cajal, E-28034 Madrid, Spain

[8] Hosp La Fe, E-46009 Valencia, Spain

[9] Hosp Santa Creu & Sant Pau, Barcelona, Spain

[10] Hosp Son Espases, Palma De Mallorca, Spain

[11] Hosp Lozano Blesa, Zaragoza, Spain

[12] Hosp Josep Trueta, Girona, Spain

[13] Hosp Donostia, Donostia San Sebastian, Spain

[14] Hosp Clin San Carlos, Madrid, Spain

[15] Hosp Univ Canarias, San Cristobal la Laguna, Spain

[16] Hosp Morales Messeguer, Murcia, Spain

[17] Hosp La Prinesa, Madrid, Spain

来源：

BONE MARROW TRANSPLANTATION | 2012年 / 47卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：S2 / S2

页数：1

共 50 条

[1] A Phase III PETHEMA/GEM Randomized Trial of Postransplant (ASCT) Maintenance in Multiple Myeloma: Superiority of Bortezomib/Thalidomide Compared with Thalidomide and Alfa-2b Interferon
Rosinol, Laura
Teresa Cibeira, Maria
Victoria Mateos, Maria
Martinez, Joaquin
Oriol, Albert
Isabel Teruel, Ana
Hernandez, Dolores
Lopez, Javier
de la Rubia, Javier
Granell, Miquel
Besalduch, Juan
Palomera, Luis
Gonzalez, Yolanda
Asuncion Etxebeste, Maria
Diaz-Mediavilla, Joaquin
Hernandez, Miguel T.
de Arriba, Felipe
Alegre, Adrian
Jose Lahuerta, Juan
San Miguel, Jesus F.
Blade, Joan
BLOOD, 2011, 118 (21) : 1694 - 1695
[2] Bortezomib and thalidomide maintenance after stem cell transplantation for multiple myeloma: a PETHEMA/GEM trial
Rosinol, L.
Oriol, A.
Teruel, A. I.
de la Guia, A. L.
Blanchard, Ma J.
de la Rubia, J.
Granell, M.
Sampol, Ma A.
Palomera, L.
Gonzalez, Y.
Etxebeste, Ma A.
Martinez-Martinez, R.
Hernandez, M. T.
de Arriba, F.
Alegre, A.
Cibeira, Ma T.
Mateos, Ma V.
Martinez-Lopez, J.
Lahuerta, J. J.
Miguel, J. San
Blade, J.
LEUKEMIA, 2017, 31 (09) : 1922 - 1927
[3] Bortezomib and thalidomide maintenance after stem cell transplantation for multiple myeloma: a PETHEMA/GEM trial
L Rosiñol
A Oriol
A I Teruel
A L de la Guía
MaJ Blanchard
J de la Rubia
M Granell
MaA Sampol
L Palomera
Y González
MaA Etxebeste
R Martínez-Martínez
M T Hernández
F de Arriba
A Alegre
MaT Cibeira
MaV Mateos
J Martínez-López
J J Lahuerta
J San Miguel
J Bladé
Leukemia, 2017, 31 : 1922 - 1927
[4] Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study
Rosinol, Laura
Oriol, Albert
Isabel Teruel, Ana
Hernandez, Dolores
Lopez-Jimenez, Javier
de la Rubia, Javier
Granell, Miquel
Besalduch, Joan
Palomera, Luis
Gonzalez, Yolanda
Asuncion Etxebeste, Ma
Diaz-Mediavilla, Joaquin
Hernandez, Miguel T.
de Arriba, Felipe
Gutierrez, Norma C.
Luisa Martin-Ramos, Ma
Teresa Cibeira, Ma
Victoria Mateos, Ma
Martinez, Joaquin
Alegre, Adrian
Jose Lahuerta, Juan
San Miguel, Jesus
Blade, Joan
BLOOD, 2012, 120 (08) : 1589 - 1596
[5] Risk adapted post-transplant maintenance in multiple myeloma
Vaxman, Iuliana
Gertz, Morie
EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (02) : 107 - 118
[6] Post-Transplant Maintenance Treatment Options in Multiple Myeloma
Dhauna Karam
Shaji Kumar
Oncology and Therapy, 2021, 9 : 69 - 88
[7] Post-Transplant Maintenance Treatment Options in Multiple Myeloma
Karam, Dhauna
Kumar, Shaji
ONCOLOGY AND THERAPY, 2021, 9 (01) : 69 - 88
[8] Safety and pharmacokinetic analysis of zoledronic acid in a multicentre randomised trial of post-transplant thalidomide maintenance therapy for multiple myeloma
Spencer, A
Roberts, A
Bailey, M
Schran, H
Lynch, K
BONE, 2004, 34 : S97 - S97
[9] A Phase III PETHEMA/GEM Study of Induction Therapy Prior Autologous Stem Cell Transplantation (ASCT) In Multiple Myeloma: Superiority of VTD (Bortezomib/Thalidomide/Dexamethasone) Over TD and VBMCP/VBAD Plus Bortezomib
Rosinol, Laura
Teresa Cibeira, Maria
Victoria Mateos, Maria
Martinez, Joaquin
Oriol, Albert
Isabel Teruel, Ana
Hernandez, Dolores
Garcia-Larana, Jose
De La Rubia, Javier
Sureda, Anna
Besalduch, Juan
Palomera, Luis
Gonzalez, Yolanda
Asuncion Etxebeste, Maria
Diaz-Media-villa, Joaquin
Hernandez, Miguel T.
de Arriba, Felipe
Alegre, Adrian
Jose Lahuerta, Juan
San Miguel, Jesus F.
Blade, Joan
BLOOD, 2010, 116 (21) : 139 - 140
[10] New Developments in Post-transplant Maintenance Treatment of Multiple Myeloma
Liu, Hong
McCarthy, Philip
SEMINARS IN ONCOLOGY, 2013, 40 (05) : 602 - 609

← 1 2 3 4 5 →